18 F-FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI) (Q24186399)

mild cognitive impairment

title

18 F-FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI) (English)

0 references

1 reference

0 references

1 reference

inferred from title

cognitive dysfunction

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25629415%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

5

Obioha Ukoumunne

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25629415%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Chris Hyde

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25629415%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Steven Martin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25629415%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Christos Sachpekidis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25629415%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Nadja Smailagic

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25629415%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

1 June 2020

publication date

28 January 2015

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25629415%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25629415%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

CD010632

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25629415%20AND%20SRC:MED&resulttype=core&format=json

Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

FDG-PET and CSF phospho-tau for prediction of cognitive decline in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

The new Alzheimer's criteria in a naturalistic series of patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Evaluation of a calibrated (18)F-FDG PET score as a biomarker for progression in Alzheimer disease and mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Comparing predictors of conversion and decline in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Principal component analysis of FDG PET in amnestic MCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Impact of molecular imaging on the diagnostic process in a memory clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Fluorodeoxyglucose positron emission tomography of mild cognitive impairment with clinical follow-up at 3 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Controlled memory processes in questionable Alzheimer's disease: a view from neuroimaging research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Automated MRI measures predict progression to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Multi-region analysis of longitudinal FDG-PET for the classification of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Decreased cortical glucose metabolism in converters from CDR 0.5 to Alzheimer's disease in a community: the Osaki-Tajiri Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Inclusion criteria provide heterogeneity in baseline profiles of patients with mild cognitive impairment: comparison of two prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Comparison of neuropsychological and FDG-PET findings between early- versus late-onset mild cognitive impairment: A five-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Amyloid deposition, hypometabolism, and longitudinal cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Longitudinal change of biomarkers in cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Vascular burden and Alzheimer disease pathologic progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

MCI patients declining and not-declining at mid-term follow-up: FDG-PET findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Predictors of cognitive change in middle-aged and older adults with memory loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Predicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Search strategies to identify diagnostic accuracy studies in MEDLINE and EMBASE

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Cholinesterase inhibitors for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Clinical features of frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

[11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

PET/MRI for neurologic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Individual cerebral metabolic deficits in Alzheimer's disease and amnestic mild cognitive impairment: an FDG PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Positron emission tomography in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Revising the definition of Alzheimer's disease: a new lexicon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Association of elevated phospho-tau levels with Alzheimer-typical 18F-fluoro-2-deoxy-D-glucose positron emission tomography findings in patients with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Global prevalence of dementia: a Delphi consensus study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Imaging markers for Alzheimer disease: which vs how

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Impairment of neocortical metabolism predicts progression in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Antemortem diagnosis of frontotemporal lobar degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

The value of PET in mild cognitive impairment, typical and atypical/unclear dementias: A retrospective memory clinic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Systematic reviews of diagnostic test accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

21 January 2018

Memantine for dementia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

The Clinical Dementia Rating (CDR): current version and scoring rules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Cost-effectiveness of 18F-fluorodeoxyglucose positron emission tomography in the assessment of early dementia from a Belgian and European perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Microglial activation and amyloid deposition in mild cognitive impairment: a PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Early Detection of Brain Pathology Suggestive of Early AD Using Objective Evaluation of FDG-PET Scans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Mild cognitive impairment: clinical characterization and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Mild cognitive impairment as a diagnostic entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Mild cognitive impairment: ten years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

IQCODE for the diagnosis of Alzheimer’s disease dementia and other dementias within a community setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

The Global Deterioration Scale for assessment of primary degenerative dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

The accuracy of 18 FDG-PET in the early diagnosis of Alzheimer’s disease dementia and other dementias in people with MCI

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010632.PUB2

Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups

21 January 2018

1 reference

12 December 2020

Is MCI really just early dementia? A systematic review of conversion studies.

1 reference

12 December 2020

Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET.

1 reference

12 December 2020

Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative

1 reference

12 December 2020

Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease

1 reference

12 December 2020

FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment

1 reference

12 December 2020

Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment.

1 reference

12 December 2020

Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.

1 reference

12 December 2020

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

1 reference

12 December 2020

SPECT in Alzheimer's disease: features associated with bilateral parietotemporal hypoperfusion.

1 reference

12 December 2020

PET imaging of amyloid deposition in patients with mild cognitive impairment.

1 reference

12 December 2020

Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits.

1 reference

12 December 2020

FDG PET imaging in patients with pathologically verified dementia.

1 reference

12 December 2020

Value of diagnostic tests to predict conversion to Alzheimer's disease in young and old patients with amnestic mild cognitive impairment

1 reference

12 December 2020

A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET

1 reference

12 December 2020

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop.

1 reference

12 December 2020

Evaluation of diagnostic procedures

1 reference

12 December 2020

A new rating scale for Alzheimer's disease.

1 reference

12 December 2020

Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.

1 reference

12 December 2020

Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome

1 reference

12 December 2020

Current concepts in mild cognitive impairment

1 reference

12 December 2020

Ten-year risk of dementia in subjects with mild cognitive impairment

1 reference

12 December 2020

Differences in hippocampal metabolism between amnestic and non-amnestic MCI subjects: automated FDG-PET image analysis.

1 reference

12 December 2020

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

1 reference

12 December 2020

A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations

1 reference

12 December 2020

18F-FDG PET studies in patients with extratemporal and temporal epilepsy: evaluation of an observer-independent analysis.

1 reference

12 December 2020

European Association of Nuclear Medicine procedure guidelines for brain imaging using [(18)F]FDG.

1 reference

12 December 2020

Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within community dwelling populations

1 reference

12 December 2020

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

1 reference

12 December 2020

Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease by SPECT.

1 reference

12 December 2020

10.1002/14651858.CD010632.PUB2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25629415%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25629415%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference